Global Genomic Cancer Panel And Profiling Market Size, Share, Growth and Demand by 2030

2025

2030

Global Genomic Cancer Panel And Profiling Market – Analysis and Forecast (2025-2030)

Industry Insight By Tissue Testing Type (Solid and Liquid), By Cancer Panel Type (Single-Gene and Multiple-Gene), By Cancer Type (Lung Cancer, Breast Cancer, Colon Cancer, Prostate Cancer and Other), By Application (Clinical and Research), By Technology (Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescence In-Situ Hybridization (FISH), Immunohistochemistry (IHC) and Others), By End-User (Hospitals, Clinical and Diagnostic Laboratories, Research and Academic Institutes and Other) and By Geography (North America, Europe, Asia-Pacific, Latin America and Rest of the World)

Ask for Customization

Request for Sample

Industry Overview

The Global Genomic Cancer Panel And Profiling Market is expected to reach USD 25.64 billion by 2030 from USD 9.20 billion in 2023. The Global Genomic Cancer Panel And Profiling Market is expected to grow at a CAGR of 8.33% during the forecast period 2025-2030.

The advancements in genomic research and an increasing focus on precision medicine within the field of oncology is driving the growth in this market. Genomic cancer panels and profiling are highly used to detect cancer by studying the genetic details of tumors before symptoms appear. The ability of the genomic cancer panels and profiling is to provide comprehensive genetic insights, facilitating early detection and the formulation of personalized treatment plans. The revolutionary potential of these technologies hold in reshaping cancer management is the main growth driver of the Genomic Cancer Panel And Profiling Market. These panels offer a more accurate means of identifying specific genetic alterations, which enable healthcare professionals to alter intervention accordingly.

Increasing demand for early cancer detection while treating cancer patients, has shown a significant growth in the Global Genomic Cancer Panel And Profiling Market. The changing lifestyle of people has increased the cancer risk, due to which there is an increased popularity and appreciation of liquid biopsy tests leading to the growth of the Global Genomic Cancer Panel And Profiling Market.

Impact of the Market

The Global Genomic Cancer Panel And Profiling Market has made an remarkable impact. Doctors choose treatments using effective genetic information. Finding cancer early has also made easier to treat and beat it in a specific time period. Personalized treatment is playing a major role in the treatment. Research and Testing new treatments has made easy to treat the cancer. Genomic profiling assists in developing appropriate follow-up plans and adjusting treatments. The progress in genomic technologies have led to the cost of genomic profiling. A large patient population is accessible to benefit from personalized cancer treatment.

Market Segmentation

Insight by Tissue Testing

Based on tissue testing type , The Global Genomic Cancer Panel And Profiling Market is segmented into Solid and liquid tissue testing. Using liquid samples for testing, rather than traditional methods, is expected to become more common and important in understanding and treating cancer and is dominating the market

Insight by Cancer Panel Type

Based on cancer panel type, The Global Genomic Cancer Panel And Profiling Market is bifurcated into single-gene panel and multi-gene panel. Multi-gene panel segment dominated the global genomic cancer panel and profiling market, as these panels, examine multiple genes simultaneously, understand and analyze cancer at the genomic level on a global scale.

Insight by Cancer Type

On the basis of cancer type, The Global Genomic Cancer Panel And Profiling Market is segregated into lung cancer, breast cancer, colon cancer, prostate cancer and other cancers. Breast cancer dominated the global genomic cancer panel and profiling market, as it is one of the most common types of cancer globally.

Insight by Application Type

On the basis of application type, The Global Genomic Cancer Panel And Profiling Market is classified into Clinical and Research. Genomic cancer panels provide critical information that helps Clinicians make more informed decisions about the most effective treatments for individual patients due to which clinical segment dominated the global genomic cancer panel and profiling market.

Insight by Technology Type

On the basis of Technology type, The Global Genomic Cancer Panel And Profiling Market is classified into Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescence In-Situ Hybridization (FISH), Immunohistochemistry (IHC) and Others. Next-Generation Sequencing (NGS) segment dominated the global genomic cancer panel and profiling market. It offers comprehensive, cost-effective, and efficient genomic analysis in the field of cancer genomics.

Insight by End-User Type

On the basis of End-User type, The Global Genomic Cancer Panel And Profiling Market is classified into Hospitals, Clinical and Diagnostic Laboratories, Research and Academic Institutes and Other End Users. Hospitals segment dominated the global genomic cancer panel and profiling market. Hospitals often have multidisciplinary teams of healthcare professionals, including oncologists, pathologists, and genetic counselors.

Global Genomic Cancer Panel And Profiling Market Report Coverage

Report Metric	Details
Historical Period	2018 - 2023
Base Year Considered	2024
Forecast Period	2025 - 2030
Market Size in 2023	U.S.D. 9.20 Billion
Revenue Forecast in 2030	U.S.D. 25.64 Billion
Growth Rate	8.33%
Segments Covered in the Report	By Tissue Testing Type, By Cancer Panel Type, By Cancer Type, By Application, By Technology and By End-User
Report Scope	Market Trends, Drivers, and Restraints; Revenue Estimation and Forecast; Segmentation Analysis; Impact of COVID-19; Companies’ Strategic Developments; Market Share Analysis of Key Players; Company Profiling
Regions Covered in the Report	North America, Europe, Asia-Pacific, Latin America and Rest of the World

Industry Dynamics

Growth Drivers

Rising need for cancer profiling in developed countries drives the demand for genomic panels and profiling tests. Larger proportion of individuals is in the elderly age group in developed countries. Cancer occurrence tends to increase with age. This trend drives a steady demand for cancer treatment and related healthcare services. Genomic cancer panels contribute to this by helping in identifying genetic markers associated with early-stage cancers. Early detection allows for timely interventions, improving treatment outcomes and reducing the overall load of the disease.

Restraints

Poor reimbursement circumstances and lack of standard regulations are the major restraints, faced by the genomic cancer panel and profiling market. Reimbursement reductions in the genomic cancer panel and profiling market have significant implications for both healthcare providers and patients. Lack of access to the testing samples, improper conditions of its storage facilities, and rise in usage of immunotherapy are the major factors that are widely restraining the overall market growth.

Geographic Overview

North America
Europe
Asia Pacific (APAC)
Latin America
Rest of the World

Based on region, North America dominated the global genomic cancer panel and profiling market in terms of market size. However, the Asia-Pacific region, is encompassing numerous emerging economies during the forecast period.

Key Players Covered in the Report

Key players of The Global Genomic Cancer Panel And Profiling Market are Agilent Technologies, Inc., Burning Rock DX, Myriad Genetics, ARUP Laboratories, Danaher Corporation (Integrated DNA Technologies, Inc.), Caris Life Sciences, Thermo Fisher Scientific, Inc., Exact Sciences Corporation, Fulgent Genetics, F. Hoffmann-La Roche Ltd., Genecast Biotechnology Co. Ltd., Illumina, Inc., Invitae Corporation.

Recent Developments by Key Players

Recently, Agilent Technologies, announced the launch of the Agilent ProteoAnalyzer system to boost capabilities in protein analysis. The Agilent ProteoAnalyzer system is a new automated parallel capillary electrophoresis system for protein analysis that brings more efficiency, versatility and reliability in protein QC workflows by automating the separation, data processing and simplifying sample preparation steps. In this way it analyzes complex protein mixtures seamlessly without compromising the accuracy of the results. Agilent is expected to gain strong momentum across the pharma, biotech, food analysis and academia sectors on the back of its latest move, as the ProteoAnalyzer system can help companies reduce training and labor costs.

In recent times, Myriad Genetics collaborated with Memorial Sloan Kettering Cancer Center (MSK) to study the use of Myriad's minimal residual disease (MRD) testing platform in predicting breast cancer treatment response. The platform is a tumor-informed high-definition assay that monitors circulating tumor DNA (ctDNA) levels via whole-genome sequencing. The partners will be studying treatment response prediction in patients with metastatic breast cancer treated with CDK4/6 inhibitors, as well as investigating the association of MRD testing with chemotherapy treatment response.

The Genomic Cancer Panel And Profiling Market report offers a comprehensive market segmentation analysis along with estimation for the forecast period 2025–2030.

Segments Covered in the Report

By Tissue Testing Type
- Solid
- Liquid
By Cancer Panel Type
- Single-gene
- Multi-gene
By Cancer Type
- Lung
- Breast
- Colon
- Prostate
- Other
By Application Type
- Clinical
- Research
By Technology Type
- Next-Generation Sequencing (NGS)
- Polymerase Chain Reaction (PCR)
- Fluorescence In-Situ Hybridization (FISH)
- Immunohistochemistry (IHC)
- Others
By End-User Type
- Hospitals
- Clinical and Diagnostic Laboratories
- Research and Academic Institutes
- Others

Region Covered in the Report

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
Asia-Pacific (APAC)
- China
- Japan
- India
Latin America
- Brazil
- Mexico
- Other Countries
Rest of the World
- Saudi Arabia
- South Africa
- U.A.E
- Other Countries

Global Genomic Cancer Panel and Profiling Market Size and Market Analysis

1. Research Overview

1.1. The Report Offers
1.2. Market Coverage
1.2.1. By Tissue Testing Type
1.2.2. By Cancer Panel Type
       1.2.3.   By Cancer Type
       1.2.4.   By Application
       1.2.5.   By Technology
1.2.6. By Region
1.3. Research Phases
1.4. Limitations
1.5. Market Methodology
1.5.1. Data Sources
1.5.1.1. Primary Research
1.5.1.2. Secondary Research
1.5.2. Methodology
1.5.2.1. Data Exploration
1.5.2.2. Forecast Parameters
1.5.2.3. Data Validation
1.5.2.4. Assumptions
1.5.3. Study Period & Data Reporting Unit

2. Executive Summary

3. Industry Overview

3.1. Industry Dynamics
3.1.1. Market Growth Drivers
3.1.2. Market Restraints
3.1.3. Key Market Trends
3.1.4. Major Opportunities
3.2. Industry Ecosystem
3.2.1. Porter’s Five Forces Analysis
3.2.2. Recent Development Analysis
3.2.3. Value Chain Analysis
3.3. Competitive Insight
3.3.1. Competitive Position of Industry Players
3.3.2. Market Attractive Analysis
3.3.3. Market Share Analysis

4. Global Market Estimate and Forecast

4.1. Global Market Overview
4.2. Global Market Estimate and Forecast to 2030

5. Market Segmentation Estimate and Forecast

5.1. By Tissue Testing Type
5.1.1. Solid and Liquid
5.1.1.1. Market Definition
5.1.1.2. Market Estimation and Forecast to 2030

5.2. By Cancer Panel Type
5.2.1. Single-Gene and Multiple-Gene
5.2.1.1. Market Definition
5.2.1.2. Market Estimation and Forecast to 2030

5.3   By Cancer Type
5.3.1. Lung Cancer
5.3.1.1. Market Definition
5.3.1.2. Market Estimation and Forecast to 2030
5.3.2. Breast Cancer
5.3.2.1. Market Definition
5.3.2.2. Market Estimation and Forecast to 2030
       5.3.3.   Colon Cancer
5.3.3.1. Market Definition
5.3.3.2. Market Estimation and Forecast to 2030
       5.3.4.   Prostate Cancer
5.3.4.1. Market Definition
5.3.4.2. Market Estimation and Forecast to 2030

   5.4.   By Application
       5.4.1.   Clinical and Research
5.4.1.1. Market Definition
5.4.1.2. Market Estimation and Forecast to 2030
   5.5.   By Technology
       5.5.1.   Next-Generation Sequencing (NGS)
5.5.1.1. Market Definition
5.5.1.2. Market Estimation and Forecast to 2030
       5.5.2.   Polymerase Chain Reaction (PCR)
  5.5.2.1. Market Definition
5.5.2.2. Market Estimation and Forecast to 2030
           Fluorescence In-Situ Hybridization (FISH)
5.5.2.1. Market Definition
5.5.2.2. Market Estimation and Forecast to 2030
       5.5.3.   Immunohistochemistry (IHC)
  5.5.3.1. Market Definition
5.5.3.2. Market Estimation and Forecast to 2030
   5.6.   By End-User
       5.6.1.   Hospitals
5.6.1.1. Market Definition
5.6.1.2. Market Estimation and Forecast to 2030
       5.6.2.   Clinical and Diagnostic Laboratories
5.5.2.1. Market Definition
5.5.2.2. Market Estimation and Forecast to 2030
       5.6.3.   Research and Academic Institutes
5.5.3.1. Market Definition
5.5.3.2. Market Estimation and Forecast to 2030

6. North America Market Estimate and Forecast

6.1. By Tissue Testing
  6.2. By Cancer Panel Type
   6.3.   By Cancer Type
   6.4.   By Application Type
   6.5.   By Technology Type
   6.6.   By End-User Type
   7.7. By Country – China, Japan, India, South Korea, and Rest of Asia-Pacific
7.7.1. U.S. Market Estimate and Forecast
7.7.2. Canada Market Estimate and Forecast
7.7.3. Mexico Market Estimate and Forecast

7. Europe Market Estimate and Forecast

  7.1. By Tissue Testing
7.2. By Cancer Panel Type
   7.3.   By Cancer Type
   7.4.   By Application Type
   7.5.   By Technology Type
   7.6.   By End-User Type
   7.7. By Country – China, Japan, India, South Korea, and Rest of Asia-Pacific
7.7.1. Germany Market Estimate and Forecast
7.7.2. France Market Estimate and Forecast
7.7.3. U.K. Market Estimate and Forecast
7.7.4. Italy Market Estimate and Forecast
7.7.5. Spain Market Estimate and Forecast
7.7.6. Rest of Europe Market Estimate and Forecast

8. Asia-Pacific Market Estimate and Forecast

8.1. By Tissue Testing
8.2. By Cancer Panel Type
   8.3.   By Cancer Type
   8.4.   By Application Type
   8.5.   By Technology Type
   8.6.   By End-User Type
  8.7. By Country – China, Japan, India, South Korea, and Rest of Asia-Pacific
8.7.1. China Market Estimate and Forecast
8.7.2. Japan Market Estimate and Forecast
8.7.3. India Market Estimate and Forecast
8.7.4. South Korea Market Estimate and Forecast
8.7.5. Singapore Market Estimate and Forecast
8.7.6. Rest of Asia-Pacific Market Estimate and Forecast

9. Rest of the World (RoW) Market Estimate and Forecast

  9.1. By Tissue Testingx`c
   9.2. By Cancer Panel Type
   9.3.   By Cancer Type
   9.4.   By Application Type
   9.5.   By Technology Type
   9.6.   By End-User Type
9.7. By Country – Brazil, Saudi Arabia, South Africa, U.A.E., and Other Countries
9.7.1. Brazil Market Estimate and Forecast
9.7.2. Saudi Arabia Market Estimate and Forecast
9.7.3. South Africa Market Estimate and Forecast
9.7.4. Other Countries Market Estimate and Forecast

10. Company Profiles

10.1. Agilent Technologies, Inc.
10.1.1. Snapshot
10.1.2. Overview
10.1.3. Offerings
10.1.4. Financial Insight
10.1.5. Recent Developments
10.2. Burning Rock DX
10.2.1. Snapshot
10.2.2. Overview
10.2.3. Offerings
10.2.4. Financial Insight
10.2.5. Recent Developments
10.3. Myriad Genetics
10.3.1. Snapshot
10.3.2. Overview
10.3.3. Offerings
10.3.4. Financial Insight
10.3.5. Recent Developments
10.4. ARUP Laboratories
10.4.1. Snapshot
10.4.2. Overview
10.4.3. Offerings
10.4.4. Financial Insight
10.4.5. Recent Developments
10.5. Danaher Corporation (Integrated DNA Technologies, Inc.)
10.5.1. Snapshot
10.5.2. Overview
10.5.3. Offerings
10.5.4. Financial Insight
10.5.5. Recent Developments
10.6. Caris Life Sciences
10.6.1. Snapshot
10.6.2. Overview
10.6.3. Offerings
10.6.4. Financial Insight
10.6.5. Recent Developments
10.7. Thermo Fisher Scientific, Inc.
10.7.1. Snapshot
10.7.2. Overview
10.7.3. Offerings
10.7.4. Financial Insight
10.7.5. Recent Developments
10.8. Exact Sciences Corporation
10.8.1. Snapshot
10.8.2. Overview
10.8.3. Offerings
10.8.4. Financial Insight
10.8.5. Recent Developments
10.9. Fulgent Genetics
10.9.1. Snapshot
10.9.2. Overview
10.9.3. Offerings
10.9.4. Financial Insight
10.9.5. Recent Developments
10.10. F. Hoffmann-La Roche Ltd.
10.10.1. Snapshot
10.10.2. Overview
10.10.3. Offerings
10.10.4. Financial Insight
10.10.5. Recent Developments
10.11. Genecast Biotechnology Co. Ltd.
10.11.1. Snapshot
10.11.2. Overview
10.11.3. Offerings
10.11.4. Financial Insight
10.11.5. Recent Developments
10.12. Illumina, Inc.
10.12.1. Snapshot
10.12.2. Overview
10.12.3. Offerings
10.12.4. Financial Insight
10.12.5. Recent Developments
   10.13.   Invitae Corporation
       10.13.1. Snapshot
10.13.2. Overview
10.13.3. Offerings
10.13.4. Financial Insight
10.13.5. Recent Developments

11. Appendix

11.1. Exchange Rates
11.2. Abbreviations

Note: Financial insight and recent developments of different companies are subject to the availability of information in the secondary domain.

List of Tables

Table 1 Tissue Testings
Table 2 Study Periods
Table 3 Data Reporting Unit
Table 4 Global Genomic Cancer Panel And Profiling Market Size, by Tissue Testing, 2018-2023 (USD Billion)
Table 5 Global Genomic Cancer Panel And Profiling Market Size, by Tissue Testing, 2025-2030 (USD Billion)
Table 6 Global Genomic Cancer Panel And Profiling Market Size, by Cancer Panel Type, 2018-2023 (USD Billion)
Table 7 Global Genomic Cancer Panel And Profiling Market Size, by Cancer Panel Type, 2025-2030 (USD Billion)
Table 8 Global Genomic Cancer Panel And Profiling Market Size, by Cancer Type, 2018-2023 (USD Billion)
Table 9 Global Genomic Cancer Panel And Profiling Market Size, by Cancer Type, 2025-2030 (USD Billion)
Table 10 Global Genomic Cancer Panel And Profiling Market Size, by Application Type, 2018-2023 (USD Billion)
Table 11 Global Genomic Cancer Panel And Profiling Market Size, by Application Type, 2025-2030 (USD Billion)
Table 12 Global Genomic Cancer Panel And Profiling Market Size, by Technology Type, 2018-2023 (USD Billion)
Table 13 Global Genomic Cancer Panel And Profiling Market Size, by Technology Type, 2025-2030 (USD Billion)
Table 14 Global Genomic Cancer Panel And Profiling Market Size, by End-User Type, 2018-2023 (USD Billion)
Table 15 Global Genomic Cancer Panel And Profiling Market Size, by End-User Type, 2025-2030 (USD Billion)
Table 16 Global Genomic Cancer Panel And Profiling Market Size, by Region, 2018-2023 (USD Billion)
Table 17 Global Genomic Cancer Panel And Profiling Market Size, by Region, 2025-2030 (USD Billion)
Table 18 North America Genomic Cancer Panel And Profiling Market Size, by Tissue Testing, 2018-2023 (USD Billion)
Table 19 North America Genomic Cancer Panel And Profiling Market Size, by Tissue Testing, 2025-2030 (USD Billion)
Table 20 North America Genomic Cancer Panel And Profiling Market Size, by Cancer Panel Type, 2018-2023 (USD Billion)
Table 21 North America Genomic Cancer Panel And Profiling Market Size, by Cancer Panel Type, 2025-2030 (USD Billion)
Table 22 North America Genomic Cancer Panel And Profiling Market Size, by Cancer Type, 2018-2023 (USD Billion)
Table 23 North America Genomic Cancer Panel And Profiling Market Size, by Cancer Type, 2025-2030 (USD Billion)
Table 24 North America Genomic Cancer Panel And Profiling Market Size, by Application Type, 2018-2023 (USD Billion)
Table 25 North America Genomic Cancer Panel And Profiling Market Size, by Application Type, 2025-2030 (USD Billion)
Table 26 North America Genomic Cancer Panel And Profiling Market Size, by Technology Type, 2018-2023 (USD Billion)
Table 27 North America Genomic Cancer Panel And Profiling Market Size, by Technology Type, 2025-2030 (USD Billion)
Table 28 North America Genomic Cancer Panel And Profiling Market Size, by End-User Type, 2018-2023 (USD Billion)
Table 29 North America Genomic Cancer Panel And Profiling Market Size, by End-User Type, 2025-2030 (USD Billion)
Table 30 North America Genomic Cancer Panel And Profiling Market Size, by Country, 2018-2023 (USD Billion)
Table 31 North America Genomic Cancer Panel And Profiling Market Size, by Country, 2025-2030 (USD Billion)
Table 32 Europe Genomic Cancer Panel And Profiling Market Size, by Tissue Testing, 2018-2023 (USD Billion)
Table 33 Europe Genomic Cancer Panel And Profiling Market Size, by Tissue Testing, 2025-2030 (USD Billion)
Table 34 Europe Genomic Cancer Panel And Profiling Market Size, by Cancer Panel Type, 2018-2023 (USD Billion)
Table 35 Europe Genomic Cancer Panel And Profiling Market Size, by Cancer Panel Type, 2025-2030 (USD Billion)
Table 36 Europe Genomic Cancer Panel And Profiling Market Size, by Cancer Type, 2018-2023 (USD Billion)
Table 37 Europe Genomic Cancer Panel And Profiling Market Size, by Cancer Type, 2025-2030 (USD Billion)
Table 38 Europe Genomic Cancer Panel And Profiling Market Size, by Application Type, 2018-2023 (USD Billion)
Table 39 Europe Genomic Cancer Panel And Profiling Market Size, by Application Type, 2025-2030 (USD Billion)
Table 40 Europe Genomic Cancer Panel And Profiling Market Size, by Technology Type, 2018-2023 (USD Billion)
Table 41 Europe Genomic Cancer Panel And Profiling Market Size, by Technology Type, 2025-2030 (USD Billion)
Table 42 Europe Genomic Cancer Panel And Profiling Market Size, by End-User Type, 2018-2023 (USD Billion)
Table 43 Europe Genomic Cancer Panel And Profiling Market Size, by End-User Type, 2025-2030 (USD Billion)
Table 44 Europe Genomic Cancer Panel And Profiling Market Size, by Country, 2018-2023 (USD Billion)
Table 45 Europe Genomic Cancer Panel And Profiling Market Size, by Country, 2025-2030 (USD Billion)
Table 46 Asia-Pacific Genomic Cancer Panel And Profiling Market Size, by Tissue Testing, 2018-2023 (USD Billion)
Table 47 Asia-Pacific Genomic Cancer Panel And Profiling Market Size, by Tissue Testing, 2025-2030 (USD Billion)
Table 48 Asia-Pacific Genomic Cancer Panel And Profiling Market Size, by Cancer Panel Type, 2018-2023 (USD Billion)
Table 49 Asia-Pacific Genomic Cancer Panel And Profiling Market Size, by Cancer Panel Type, 2025-2030 (USD Billion)
Table 50 Asia-Pacific Genomic Cancer Panel And Profiling Market Size, by Cancer Type, 2018-2023 (USD Billion)
Table 51 Asia-Pacific Genomic Cancer Panel And Profiling Market Size, by Cancer Type, 2025-2030 (USD Billion)
Table 52 Europe Genomic Cancer Panel And Profiling Market Size, by Application Type, 2018-2023 (USD Billion)
Table 53 Europe Genomic Cancer Panel And Profiling Market Size, by Application Type, 2025-2030 (USD Billion)
Table 54 Europe Genomic Cancer Panel And Profiling Market Size, by Technology Type, 2018-2023 (USD Billion)
Table 55 Europe Genomic Cancer Panel And Profiling Market Size, by Technology Type, 2025-2030 (USD Billion)
Table 56 Europe Genomic Cancer Panel And Profiling Market Size, by End-User Type, 2018-2023 (USD Billion)
Table 57 Europe Genomic Cancer Panel And Profiling Market Size, by End-User Type, 2025-2030 (USD Billion)
Table 58 Asia-Pacific Genomic Cancer Panel And Profiling Market Size, by Country, 2018-2023 (USD Billion)
Table 59 Asia-Pacific Genomic Cancer Panel And Profiling Market Size, by Country, 2025-2030 (USD Billion)
Table 60 RoW Genomic Cancer Panel And Profiling Market Size, by Tissue Testing, 2018-2023 (USD Billion)
Table 61 RoW Genomic Cancer Panel And Profiling Market Size, by Tissue Testing, 2025-2030 (USD Billion)
Table 62 RoW Genomic Cancer Panel And Profiling Market Size, by Cancer Panel Type, 2018-2023 (USD Billion)
Table 63 RoW Genomic Cancer Panel And Profiling Market Size, by Cancer Panel Type, 2025-2030 (USD Billion)
Table 64 RoW Genomic Cancer Panel And Profiling Market Size, by Cancer Type, 2018-2023 (USD Billion)
Table 65 RoW Genomic Cancer Panel And Profiling Market Size, by Cancer Type, 2025-2030 (USD Billion)
Table 66 RoW Genomic Cancer Panel And Profiling Market Size, by Application Type, 2018-2023 (USD Billion)
Table 67 RoW Genomic Cancer Panel And Profiling Market Size, by Application Type, 2025-2030 (USD Billion)
Table 68 RoW Genomic Cancer Panel And Profiling Market Size, by Technology Type, 2018-2023 (USD Billion)
Table 69 RoW Genomic Cancer Panel And Profiling Market Size, by Technology Type, 2025-2030 (USD Billion)
Table 70 Europe Genomic Cancer Panel And Profiling Market Size, by End-User Type, 2018-2023 (USD Billion)
Table 71 Europe Genomic Cancer Panel And Profiling Market Size, by End-User Type, 2025-2030 (USD Billion)
Table 72 RoW Genomic Cancer Panel And Profiling Market Size, by Country, 2018-2023 (USD Billion)
Table 73 RoW Genomic Cancer Panel And Profiling Market Size, by Country, 2025-2030 (USD Billion)
Table 74 Snapshot – Agilent Technologies, Inc.
Table 75 Snapshot – Burning Rock DX
Table 76 Snapshot – Myriad Genetics
Table 77 Snapshot – ARUP Laboratories
Table 78 Snapshot – Danaher Corporation (Integrated DNA Technologies, Inc.)
Table 79 Snapshot – Caris Life Sciences
Table 80 Snapshot – Thermo Fisher Scientific, Inc.
Table 81 Snapshot – Exact Sciences Corporation
Table 82 Snapshot – Fulgent Genetics
Table 83 Snapshot – F. Hoffmann-La Roche Ltd.
Table 84 Snapshot – Genecast Biotechnology Co. Ltd.
Table 85 Snapshot – Illumina, Inc.
Table 86 Snapshot – Invitae Corporation

List of Figures

Figure 1 Market Coverage
Figure 2 Research Phases
Figure 3 Secondary Tissue Testings for Different Parameters
Figure 4 Methodology
Figure 5 Data Mining & Exploration
Figure 6 Data Triangulation
Figure 7 Assumptions for Market Estimation and Forecast
Figure 8 Market Synopsis
Figure 9 Global Genomic Cancer Panel And Profiling Market - Growth Drivers and Restraints
Figure 10 Competitive Benchmark
Figure 11 Global Genomic Cancer Panel And Profiling Market Highlight
Figure 12 Global Genomic Cancer Panel And Profiling Market Size, by Tissue Testing, 2018 – 2030 (USD Billion)
Figure 13 Global Genomic Cancer Panel And Profiling Market Size, by Cancer Panel Type 2018 – 2030 (USD Billion)
Figure 14 Global Genomic Cancer Panel And Profiling Market Size, by Cancer Type 2018 – 2030 (USD Billion)
Figure 15 Global Genomic Cancer Panel And Profiling Market Size, by Application Type 2018 – 2030 (USD Billion)
Figure 16 Global Genomic Cancer Panel And Profiling Market Size, by Technology Type 2018 – 2030 (USD Billion)
Figure 17 Global Genomic Cancer Panel And Profiling Market Size, by End-User Type 2018 – 2030 (USD Billion)
Figure 18 Global Genomic Cancer Panel And Profiling Market Size, by Region, 2018 – 2030 (USD Billion)
Figure 19 North America Genomic Cancer Panel And Profiling Market Highlight
Figure 20 North America Genomic Cancer Panel And Profiling Market Size, by Tissue Testing, 2018 – 2030 (USD Billion)
Figure 21 North America Genomic Cancer Panel And Profiling Market Size, by Cancer Panel Type 2018–2030 (USD Billion)
Figure 22 North America Genomic Cancer Panel And Profiling Market Size, by Cancer Type 2018–2030 (USD Billion)
Figure 23 North America Genomic Cancer Panel And Profiling Market Size, by Application Type 2018–2030 (USD Billion)
Figure 24 Global Genomic Cancer Panel And Profiling Market Size, by Technology Type 2018 – 2030 (USD Billion)
Figure 25 Global Genomic Cancer Panel And Profiling Market Size, by End-User Type 2018 – 2030 (USD Billion)
Figure 26 North America Genomic Cancer Panel And Profiling Market Size, by Country, 2018 – 2030 (USD Billion)
Figure 27 Europe Genomic Cancer Panel And Profiling Market Highlight
Figure 28 Europe Genomic Cancer Panel And Profiling Market Size, by Tissue Testing, 2018 – 2030 (USD Billion)
Figure 29 Europe Genomic Cancer Panel And Profiling Market Size, by Cancer Panel Type 2018 – 2030 (USD Billion)
Figure 30 Europe Genomic Cancer Panel And Profiling Market Size, by Cancer Type 2018 – 2030 (USD Billion)
Figure 31 Europe Genomic Cancer Panel And Profiling Market Size, by Application Type 2018 – 2030 (USD Billion)
Figure 32 Global Genomic Cancer Panel And Profiling Market Size, by Technology Type 2018 – 2030 (USD Billion)
Figure 33 Global Genomic Cancer Panel And Profiling Market Size, by End-User Type 2018 – 2030 (USD Billion)
Figure 34 Europe Genomic Cancer Panel And Profiling Market Size, by Country, 2018 – 2030 (USD Billion)
Figure 35 Asia-Pacific Genomic Cancer Panel And Profiling Market Highlight
Figure 36 Asia-Pacific Genomic Cancer Panel And Profiling Market Size, by Tissue Testing, 2018 – 2030 (USD Billion)
Figure 37 Asia-Pacific Genomic Cancer Panel And Profiling Market Size, by Cancer Panel Type 2018 – 2030 (USD Billion)
Figure 38 Asia-Pacific Genomic Cancer Panel And Profiling Market Size, by Cancer Type 2018 – 2030 (USD Billion)
Figure 39 Asia-Pacific Genomic Cancer Panel And Profiling Market Size, by Application Type 2018 – 2030 (USD Billion)
Figure 40 Global Genomic Cancer Panel And Profiling Market Size, by Technology Type 2018 – 2030 (USD Billion)
Figure 41 Global Genomic Cancer Panel And Profiling Market Size, by End-User Type 2018 – 2030 (USD Billion)
Figure 42 Asia-Pacific Genomic Cancer Panel And Profiling Market Size, by Country, 2018 – 2030 (USD Billion)
Figure 43 RoW Genomic Cancer Panel And Profiling Market Highlight
Figure 44 RoW Genomic Cancer Panel And Profiling Market Size, by Tissue Testing, 2018 – 2030 (USD Billion)
Figure 45 RoW Genomic Cancer Panel And Profiling Market Size, by Cancer Panel Type 2018 – 2030 (USD Billion)
Figure 46 RoW Genomic Cancer Panel And Profiling Market Size, by Cancer Type 2018 – 2030 (USD Billion)
Figure 47 RoW Genomic Cancer Panel And Profiling Market Size, by Application Type 2018 – 2030 (USD Billion)
Figure 48 Global Genomic Cancer Panel And Profiling Market Size, by Technology Type 2018 – 2030 (USD Billion)
Figure 49 Global Genomic Cancer Panel And Profiling Market Size, by End-User Type 2018 – 2030 (USD Billion)
Figure 50 RoW Genomic Cancer Panel And Profiling Market Size, by Country, 2018 – 2030 (USD Billion)

Purchase Options

Enquire Before Buying

Ask for Customization

Latest Report

Research Methodology

Desk Research / Pilot Interviews
Build Market Size Model
Research and Analysis
Final Deliverabvle

Connect With Our Sales Team